MAPK3 and B-cell non-Hodgkin lymphoma: These results imply that activated ERK1/2 MAPK could be involved in resistance to TGF-β in B-cell lymphoma cell lines, although phosphorylation of the linker region of Smad2 seems not to be the mechanism.